Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin

…, JD González, S Negri… - Blood, The Journal …, 2008 - ashpublications.org
An understanding of the prognostic factors associated with the various forms of induction
mortality in patients with acute promyelocytic leukemia (APL) has remained remarkably limited. …

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome …

…, JD González, S Negri… - Blood, The Journal …, 2009 - ashpublications.org
Differentiation syndrome (DS) can be a life-threatening complication in patients with acute
promyelocytic leukemia (APL) undergoing induction therapy with all-trans retinoic acid (ATRA)…

Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results

…, J Bergua, T Lamy, A Vekhoff, S Negri… - Blood, The Journal …, 2008 - ashpublications.org
All-trans retinoic acid (ATRA) plus anthracycline chemotherapy is the reference treatment of
newly diagnosed acute promyelocytic leukemia (APL), whereas the role of cytosine …

Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives

…, E Zinellu, P Pirina, S Negri… - European …, 2018 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is a disabling condition that is characterised
by poorly reversible airflow limitation and inflammation. Acute exacerbations of COPD are a …

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 …

…, R Parody, JM Bergua, A León, S Negri… - Blood, The Journal …, 2008 - ashpublications.org
A previous report of the Programa de Estudio y Tratamiento de las Hemopatías Malignas (PETHEMA)
Group showed that a risk-adapted strategy combining all-trans retinoic acid (ATRA…

[HTML][HTML] Blood cell count derived inflammation indexes in patients with idiopathic pulmonary fibrosis

…, E Sotgiu, S Mellino, AA Mangoni, E Zinellu, S Negri… - Lung, 2020 - Springer
Purpose Inflammation and immunity play a pivotal but yet unclear role in idiopathic
pulmonary fibrosis (IPF), a chronic disorder characterized by progressive damage of lung …

[HTML][HTML] Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline …

…, C Rivas, M González, JD González, S Negri… - …, 2009 - ncbi.nlm.nih.gov
… González, 17 Silvia Negri, 18 Salut Brunet, 19 Bob Lowenberg, 20 and Miguel A. Sanz 1 …
Negri; Instituto Privado de Hematología, Paraná; Instituto de Trasplante de Médula Ósea …

[HTML][HTML] Effects of pirfenidone and nintedanib on markers of systemic oxidative stress and inflammation in patients with idiopathic pulmonary fibrosis: a preliminary …

AG Fois, E Sotgiu, V Scano, S Negri, S Mellino… - Antioxidants, 2020 - mdpi.com
Introduction: In vitro evidence suggests that pirfenidone and nintedanib, approved agents
for the treatment of idiopathic pulmonary fibrosis (IPF), exert anti-inflammatory and anti-oxidant …

Association between routine blood biomarkers and clinical phenotypes and exacerbations in chronic obstructive pulmonary disease

…, R Petkov, N Yanev, P Pirina, S Negri… - … journal of chronic …, 2020 - Taylor & Francis
Introduction Chronic obstructive pulmonary disease (COPD) is associated with increased
lung and systemic inflammation. We aimed to identify associations between easy-to-obtain …

Point-of-care testing for HCV infection: recent advances and implications for alternative screening.

…, C Mabellini, T Belloni, L Brignolo, S Negri… - The New …, 2014 - europepmc.org
Over the last few years, hepatitis C virus (HCV) infection has emerged as one of the most
significant causes of chronic liver disease worldwide, with an estimated prevalence ranging …